Your email has been successfully added to our mailing list.

×
-0.0492361180020361 -0.0492361180020361 -0.0492361180020361 -0.0492361180020361 -0.0492361180020361 -0.0492361180020361 -0.0492361180020361 -0.0492361180020361
Stock impact report

Comprehensive Insight on the Scleroderma Drug Pipeline Landscape Revealed in the Latest 2024 Report [Yahoo! Finance]

MITSUBISHI CH GRP U/ADR (MTLHY) 
NASDAQ:AMEX Investor Relations: mitsubishichem-hd.co.jp/english/ir
Company Research Source: Yahoo! Finance
Current treatment regimens focus on symptom management and preventing the progression of the disease, but early diagnosis and intervention are crucial due to the progressive nature of the disease. Some of the emerging drug candidates for Scleroderma treatment include MT-0551 by Mitsubishi Tanabe Pharma Corporation, FT011 by Certa Therapeutics, and AM1476 by AnaMar AB, with some reaching as far as Phase III of clinical trials, signifying an unrelenting commitment to research and innovation within the scientific community. Strategic collaborations, licensing efforts, mergers and acquisitions are shaping the future of Scleroderma research and drug development, signaling a concentrated and collaborative effort across the pharmaceutical industry to bring forward novel treatments for this chronic condition. The Scleroderma drug pipeline report for 2024 has provided a complete analysis of the advancements in treatment options for Scleroderma, with over 45 companies globally involved, i Show less Read more
Impact Snapshot
Event Time:
MTLHY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
MTLHY alerts

from News Quantified
Opt-in for
MTLHY alerts

from News Quantified